Commentary: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's ranibizumab with lucentis in patients with neovascular age-related macular degeneration.
Indian J Ophthalmol
; 70(8): 3014-3015, 2022 08.
Article
en En
| MEDLINE
| ID: mdl-35918963
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Degeneración Macular Húmeda
/
Degeneración Macular
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Idioma:
En
Revista:
Indian J Ophthalmol
Año:
2022
Tipo del documento:
Article